ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025
Future Goals and Long-term Vision of the Infectious Diseases Clinical Research Consortium/Vaccine and Treatment Evaluation Unit Network.
Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial.The Lancet. Infectious diseases · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The Infectious Diseases Clinical Research Consortium and Vaccine Treatment Evaluation Units (VTEUs) are a network of clinicians and scientists who work together with the National Institutes of Allergy and Infectious Diseases to advance vaccines and therapeutics to combat infectious diseases. For more than 60 years, the VTEUs have led Phase 1-4 clinical trials, with a strong focus on Phase 1/2 trials, evaluating the safety, reactogenicity, optimal doses, routes of administration, and schedules for vaccines and treatments. Our future goals focus on advancing vaccine science and innovation through clinical and translational studies; achieving equitable representation in clinical trials across the human lifespan to facilitate disease prevention in vulnerable populations; advancing national and global health priorities through collaborations that leverage complementary strengths and foster preparedness and rapid responses; and developing the next generation of clinical and translational researchers through structured mentorship and training opportunities. Our long-term vision is to develop safe and effective vaccines and therapeutics to combat infectious diseases and enhance health and well-being for all.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.